COURTNEY HOPKINS: Open Payments
NPI 1659046738 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,761 in 168 payments from 15 companies in 2025. Trend: 2023 $3,643 · 2024 $2,492 · 2025 $2,761
Food & beverage: $2,761
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $362 |
| Lundbeck LLC | 17 | $343 |
| Alkermes, Inc. | 15 | $324 |
| Otsuka America Pharmaceutical, Inc. | 20 | $297 |
| ABBVIE INC. | 19 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $235 |
| Neurocrine BioSciences, Inc. | 12 | $213 |
| Teva Pharmaceuticals USA, Inc. | 10 | $180 |
| Vanda Pharmaceuticals Inc. | 16 | $172 |
| Noven Therapeutics, LLC | 12 | $144 |
Products named: ARISTADA, REXULTI, ABILIFY MAINTENA, VRAYLAR, CAPLYTA, INGREZZA, INVEGA SUSTENNA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
